These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24011202)

  • 1. [Ketamine for treatment of depression?].
    Vinberg M
    Ugeskr Laeger; 2013 Sep; 175(37):2089. PubMed ID: 24011202
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ketamine for treatment of acute depression].
    Hjerrild S; Bjerre J; Pedersen RH; Videbech P
    Ugeskr Laeger; 2013 Sep; 175(37):2090-3. PubMed ID: 24011203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine as an antidepresessant: a brief research history.
    Wanderer JP; Rathmell JP
    Anesthesiology; 2014 Jul; 121(1):A29. PubMed ID: 24936933
    [No Abstract]   [Full Text] [Related]  

  • 4. Ketamine for treatment-resistant depression: ready or not for clinical use?
    Rush AJ
    Am J Psychiatry; 2013 Oct; 170(10):1079-81. PubMed ID: 23982324
    [No Abstract]   [Full Text] [Related]  

  • 5. Evolving Issues in the Treatment of Depression.
    Köhler-Forsberg O; Cusin C; Nierenberg AA
    JAMA; 2019 Jun; 321(24):2401-2402. PubMed ID: 31125042
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case report.
    Gálvez V; O'Keefe E; Cotiga L; Leyden J; Harper S; Glue P; Mitchell PB; Somogyi AA; DeLory A; Loo CK
    Biol Psychiatry; 2014 Aug; 76(3):e1-2. PubMed ID: 24507509
    [No Abstract]   [Full Text] [Related]  

  • 7. A word to the wise about ketamine.
    Schatzberg AF
    Am J Psychiatry; 2014 Mar; 171(3):262-4. PubMed ID: 24585328
    [No Abstract]   [Full Text] [Related]  

  • 8. Electroconvulsive therapy is a standard treatment; ketamine is not (yet).
    Kellner CH; Greenberg RM; Ahle GM; Liebman LS
    Am J Psychiatry; 2014 Jul; 171(7):796. PubMed ID: 24980176
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Zhang and Ho: Addressing Ketamine's Use in Depression.
    Newport DJ; Nemeroff CB
    Am J Psychiatry; 2016 Apr; 173(4):431-2. PubMed ID: 27035536
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of ketamine vs. ECT in major depressive disorder: need for ECT standard dosing and duration parameters.
    Campion P
    Psychiatry Res; 2015 Jan; 225(1-2):216. PubMed ID: 25511507
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ketamine--a new treatment option for therapy-resistant depression].
    Köhler S; Betzler F
    Fortschr Neurol Psychiatr; 2015 Feb; 83(2):91-7. PubMed ID: 25723773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical Appraisal of Existing Ketamine Trials: Existing Limitations and Limited Applicability for Treatment.
    Zhang MW; Ho R
    Am J Psychiatry; 2016 Apr; 173(4):431. PubMed ID: 27035535
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood D-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine.
    Hashimoto K
    Psychopharmacology (Berl); 2014 Oct; 231(20):4081-2. PubMed ID: 25189793
    [No Abstract]   [Full Text] [Related]  

  • 14. Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.
    Bartova L; Weidenauer A; Dold M; Naderi-Heiden A; Kasper S; Willeit M; Praschak-Rieder N
    J ECT; 2017 Sep; 33(3):e31-e32. PubMed ID: 28520578
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketamine as an alternative treatment for treatment-resistant depression.
    Dowben JS; Grant JS; Keltner NL
    Perspect Psychiatr Care; 2013 Jan; 49(1):2-4. PubMed ID: 23293991
    [No Abstract]   [Full Text] [Related]  

  • 16. Speed of response to electroconvulsive therapy compared with ketamine.
    Kellner CH; ; Lisanby SH; Weiner R; Prudic J; Rudorfer MV; Young RC; Petrides G; McCall WV; Husain M; Greenberg RM; Knapp RG
    Psychiatry Res; 2015 Jan; 225(1-2):215. PubMed ID: 25511506
    [No Abstract]   [Full Text] [Related]  

  • 17. Ketamine and Other Glutamate Receptor Modulators for Depression in Bipolar Disorder in Adults.
    van Wissen K; Blanchard D
    Issues Ment Health Nurs; 2017 Jun; 38(6):526-527. PubMed ID: 28605240
    [No Abstract]   [Full Text] [Related]  

  • 18. Ketamine: A Paradigm Shift for Depression Research and Treatment.
    Krystal JH; Abdallah CG; Sanacora G; Charney DS; Duman RS
    Neuron; 2019 Mar; 101(5):774-778. PubMed ID: 30844397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketamine and the potential role for rapid-acting antidepressant medications.
    Krystal JH
    Swiss Med Wkly; 2007 Apr; 137(15-16):215-6. PubMed ID: 17525875
    [No Abstract]   [Full Text] [Related]  

  • 20. NMDA antagonist treatment of depression.
    Williams NR; Schatzberg AF
    Curr Opin Neurobiol; 2016 Feb; 36():112-7. PubMed ID: 26687375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.